Results for tag: "Elelyso"

Elelyso is a drug used to treat Gaucher disease, a rare genetic disorder that affects the body's ability to break down and store fat. It is a type of endocrine and metabolic disorder drug, which are used to treat a variety of conditions related to hormones and metabolism. Elelyso is a recombinant form of the enzyme glucocerebrosidase, which is deficient in people with Gaucher disease. It is administered via subcutaneous injection and helps to reduce the accumulation of fatty substances in the body. Elelyso is marketed by Pfizer, a global pharmaceutical company, and is available in the United States, Europe, and other countries. Other companies in the market include Sanofi, Shire, and Genzyme. Show Less Read more